Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research
In Their Words

Education and Training

  • Fellow In Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow In Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.D., Duke University, 1993

Publications

Shuldiner, SR, Gong, L, Muir, AJ, Altman, RB, and Klein, TE. "PharmGKB summary: peginterferon-α pathway." Pharmacogenetics and genomics 25, no. 9 (September 2015): 465-474.

PMID
26111151
Full Text

Ahmad, T, Yin, P, Saffitz, J, Pockros, PJ, Lalezari, J, Shiffman, M, Freilich, B, Zamparo, J, Brown, K, Dimitrova, D, Kumar, M, Manion, D, Heath-Chiozzi, M, Wolf, R, Hughes, E, Muir, AJ, and Hernandez, AF. "Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C." Hepatology (Baltimore, Md.) 62, no. 2 (August 2015): 409-416.

PMID
25251156
Full Text

Muir, AJ. "Understanding the Complexities of Cirrhosis." Clinical therapeutics 37, no. 8 (August 2015): 1822-1836. (Review)

PMID
26188836
Full Text

Giannini, EG, Afdhal, NH, Sigal, SH, Muir, AJ, Reddy, KR, Vijayaraghavan, S, Elkashab, M, Romero-Gómez, M, Dusheiko, GM, Iyengar, M, Vasey, SY, Campbell, FM, and Theodore, D. "Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy." Journal of gastroenterology and hepatology 30, no. 8 (August 2015): 1301-1308.

PMID
25777337
Full Text

Poordad, F, Sievert, W, Mollison, L, Bennett, M, Tse, E, Bräu, N, Levin, J, Sepe, T, Lee, SS, Angus, P, Conway, B, Pol, S, Boyer, N, Bronowicki, J-P, Jacobson, I, Muir, AJ, Reddy, KR, Tam, E, Ortiz-Lasanta, G, de Lédinghen, V, Sulkowski, M, Boparai, N, McPhee, F, Hughes, E, Swenson, ES, Yin, PD, and UNITY-1 Study Group, . "Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection." JAMA 313, no. 17 (May 2015): 1728-1735.

PMID
25942723
Full Text

Muir, AJ, Poordad, F, Lalezari, J, Everson, G, Dore, GJ, Herring, R, Sheikh, A, Kwo, P, Hézode, C, Pockros, PJ, Tran, A, Yozviak, J, Reau, N, Ramji, A, Stuart, K, Thompson, AJ, Vierling, J, Freilich, B, Cooper, J, Ghesquiere, W, Yang, R, McPhee, F, Hughes, EA, Swenson, ES, and Yin, PD. "Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis." JAMA 313, no. 17 (May 2015): 1736-1744.

PMID
25942724
Full Text

Flamm, SL, Muir, AJ, Fried, MW, Reddy, KR, Nelson, DR, Bzowej, NH, Sullivan, JC, Bengtsson, L, DeMasi, R, Wright, CI, Kieffer, TL, George, S, Adda, N, and Dusheiko, GM. "Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity." Journal of clinical gastroenterology 49, no. 4 (April 2015): 336-344.

PMID
24828357
Full Text

Naggie, S, Patel, K, Yang, L-Y, Chow, S-C, Johnson, V, Guyton, JR, Muir, AJ, Sulkowski, M, and Hicks, C. "Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals." Open forum infectious diseases 2, no. 2 (April 2015): ofv066-.

PMID
26110167
Full Text

Gordon, SC, Muir, AJ, Lim, JK, Pearlman, B, Argo, CK, Ramani, A, Maliakkal, B, Alam, I, Stewart, TG, Vainorius, M, Peter, J, Nelson, DR, Fried, MW, Reddy, KR, and HCV-TARGET study group, . "Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET." Journal of hepatology 62, no. 2 (February 2015): 286-293.

PMID
25218788
Full Text

Charlton, M, Gane, E, Manns, MP, Brown, RS, Curry, MP, Kwo, PY, Fontana, RJ, Gilroy, R, Teperman, L, Muir, AJ, McHutchison, JG, Symonds, WT, Brainard, D, Kirby, B, Dvory-Sobol, H, Denning, J, Arterburn, S, Samuel, D, Forns, X, and Terrault, NA. "Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation." Gastroenterology 148, no. 1 (January 2015): 108-117.

PMID
25304641
Full Text

Pages